- AustraliaNorth AmericaWorld
Investing News NetworkYour trusted source for investing success
- Lithium Outlook
- Oil and Gas Outlook
- Gold Outlook Report
- Uranium Outlook
- Rare Earths Outlook
- All Outlook Reports
- Top Generative AI Stocks
- Top EV Stocks
- Biggest AI Companies
- Biggest Blockchain Stocks
- Biggest Cryptocurrency-mining Stocks
- Biggest Cybersecurity Companies
- Biggest Robotics Companies
- Biggest Social Media Companies
- Biggest Technology ETFs
- Artificial Intellgience ETFs
- Robotics ETFs
- Canadian Cryptocurrency ETFs
- Artificial Intelligence Outlook
- EV Outlook
- Cleantech Outlook
- Crypto Outlook
- Tech Outlook
- All Market Outlook Reports
- Cannabis Weekly Round-Up
- Top Alzheimer's Treatment Stocks
- Top Biotech Stocks
- Top Plant-based Food Stocks
- Biggest Cannabis Stocks
- Biggest Pharma Stocks
- Longevity Stocks to Watch
- Psychedelics Stocks to Watch
- Top Cobalt Stocks
- Small Biotech ETFs to Watch
- Top Life Science ETFs
- Biggest Pharmaceutical ETFs
- Life Science Outlook
- Biotech Outlook
- Cannabis Outlook
- Pharma Outlook
- Psychedelics Outlook
- All Market Outlook Reports
ICL Reports Net Earnings of $75 Million in Second Quarter Results
Israel Chemicals (NYSE:ICL) announced its second quarter financial and operational highlights, which showed sales of $1.2 billion, down 22 percent from Q2 2014.
Israel Chemicals (NYSE:ICL) announced its second quarter financial and operational highlights, which showed sales of $1.2 billion, down 22 percent from Q2 2014.
As quoted in the press release:
ICL’s sales in the second quarter were $1.2 billion, down 22% from the comparable quarter in 2014 primarily due to a strike at two of its Israeli plants which concluded during the quarter. Operating income for Q2 totaled$107 million. Adjusted operating income for the second quarter of 2015 totaled $251 million compared to $243 million for Q2 2014. Net income for Q2 2015 totaled $75 million compared to $68 million for Q2 2014, and on an adjusted basis, net income was $177 million compared to $214 million for Q2 2014.
Highlights:
- Sales of $1.2B, down 22% from Q2’14 primarily due to strike at two plants in Israel
- Reported operating income of $107M, up 37% over Q2’14; Adjusted operating income of $251M
- Net income of $75M, up 10% from Q2 ’14
- Potash production at the Dead Sea returns to pre-strike levels, ramping up towards 4 million tonnes thus compensating for the strike losses
- Improved efficiency and managerial control following completion of the strike –
- Strategic progress marked by advances in the phosphate JV in China and completion of the Allana Potash acquisition
Stefan Borgas, president and CEO of ICL, commented:
During the second quarter we achieved important milestones in implementing vital efficiency measures that will help two of our major sites in Israel to regain and improve their competitiveness in the highly challenging potash and bromine markets in which we operate, as well as allow management to gain back control over the plants. The measures we are taking, including reducing labor costs and improving work standards at the plants, as well as the freedom we will now have to implement a Shared Services Center in Israel and pursue operational excellence, are in line with our strategic goal to improve our competitive position throughout our global operations. While ICL’s second quarter sales were sharply lower as a result of the strike, we are very pleased that it has concluded with important achievements for the Company and with less financial impact than initially anticipated.
Click here to read the full Israel Chemicals (NYSE:ICL) press release.
Latest News
Investing News Network websites or approved third-party tools use cookies. Please refer to the cookie policy for collected data, privacy and GDPR compliance. By continuing to browse the site, you agree to our use of cookies.